10名患有炎症性粉红的儿童的管理与局部的伊弗梅丁
Federica Dall'Oglio1, Maria Rita Nasca1, Aurora Tedeschi1
1Dermatology Clinic, University of Catania, Catania, Italy.
Pediatric dermatology
|October 31, 2024
概括
伊弗梅克丁 (IVM) 1% 乳液每天应用一次,有效治疗了10名儿童在12周内发生的炎症性粉红病. 这项研究表明,IVM奶油是一种有前途的治疗选择,用于儿科红.
科学领域:
- 皮肤病学 皮肤病学
- 儿科医学 儿科医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在儿童中诊断和治疗粉红,由于它的稀有性,存在独特的挑战.
- 缺乏批准的药理疗法治疗儿科疹.
研究的目的:
- 为了评估临床响应每天一次的艾弗麦克丁 (IVM) 1% 奶油在儿童中轻度至重度炎症性粉红病.
- 用临床和仪器监测方法评估IVM奶油的疗效.
主要方法:
- 一系列病例涉及10名患有炎症性粉红病的儿童,他们用IVM 1%奶油治疗了12周.
- 临床评估包括研究人员红疹严重性评估 (IESA) 和研究人员全球严重性评估 (IGA-S).
- 仪器监测使用皮肤镜和红斑导向数字摄影 (EDDP).
主要成果:
- 与基线相比,在治疗后观察到显著的临床改善 (IESA: 2.3 与 0.5; IGA-S: 2.1 与 0.3).
- 调查人员对全球有效性的全球评估 (IGA-GE) 显示了积极的结果 (0=55%,1=33%,3=11%).
- 仪器监测证实了临床发现 (EDDP:2.7与0.6).
结论:
- 每天使用一次的Ivermectin 1%奶油在治疗儿科粉红方面表现出有效性.
- 对于被诊断患有粉红的儿童来说,IVM奶油可能是一个可行的治疗选择.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
222
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
222
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353


